CDT EQUITY INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
CDT EQUITY INC. (CDT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$22.07 million for the 12-month period ending 2025-12-31, per its S-1 filed 2026-09-08.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-09-08
- CDT EQUITY INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$1.99M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$22.07M S-1 · filed 2026-09-08 |
| 2024-12-31 | -$12.86M S-1 · filed 2026-09-08 |
| 2023-12-31 | -$1.99M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |